Pages that link to "Q89912865"
Jump to navigation
Jump to search
The following pages link to Jaroslaw P. Maciejewski (Q89912865):
Displaying 50 items.
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 (Q24306181) (← links)
- FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q) (Q24644421) (← links)
- Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML (Q24645177) (← links)
- Defects in spliceosomal machinery: a new pathway of leukaemogenesis (Q26823040) (← links)
- Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis (Q27308738) (← links)
- Somatic STAT3 mutations in large granular lymphocytic leukemia (Q27851792) (← links)
- Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms (Q28114904) (← links)
- The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation (Q28240978) (← links)
- Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms (Q29039802) (← links)
- The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia (Q30303161) (← links)
- The complexity of interpreting genomic data in patients with acute myeloid leukemia (Q31149503) (← links)
- SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD. (Q33306707) (← links)
- Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia (Q33376903) (← links)
- Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria (Q33377654) (← links)
- Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes (Q33382047) (← links)
- A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia (Q33392366) (← links)
- Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry (Q33558763) (← links)
- Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation (Q33615619) (← links)
- Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells (Q33629603) (← links)
- Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia. (Q33652652) (← links)
- Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab (Q33707389) (← links)
- Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia (Q33722741) (← links)
- Molecular features of early onset adult myelodysplastic syndrome (Q33746718) (← links)
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies (Q33788643) (← links)
- Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes (Q33813750) (← links)
- A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction. (Q33828560) (← links)
- Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms (Q33880512) (← links)
- The role of FAS-mediated apoptosis in chronic myelogenous leukemia (Q33884594) (← links)
- Cx25 contributes to leukemia cell communication and chemosensitivity. (Q34044927) (← links)
- Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia (Q34121781) (← links)
- Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial (Q34155752) (← links)
- MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia (Q34166559) (← links)
- Genetic alterations of the cohesin complex genes in myeloid malignancies. (Q34170374) (← links)
- Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. (Q34311583) (← links)
- STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients (Q34362636) (← links)
- Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. (Q34384728) (← links)
- Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198. (Q34493791) (← links)
- Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network (Q34540749) (← links)
- The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria (Q34567835) (← links)
- Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. (Q34578265) (← links)
- Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia (Q34612362) (← links)
- Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis (Q34637945) (← links)
- Revised international prognostic scoring system for myelodysplastic syndromes (Q34639717) (← links)
- Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Ne (Q34645147) (← links)
- Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. (Q34750590) (← links)
- Mutations in G protein β subunits promote transformation and kinase inhibitor resistance (Q34893087) (← links)
- The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes (Q35244865) (← links)
- Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells (Q35603613) (← links)
- Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha (Q35753247) (← links)
- Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia (Q36022532) (← links)